(1 - 9 from 11
)
RCT ties up with Isogenica to provide high throughput display & screening ...
pharmabiz.com
[pharmabiz.com] - The pairing of CIS display with our Abdurins platform will be an attractive offering to potential partners," stated Dr Kurt Gehlsen, vice president and CSO of RCT. Dr Kevin Matthews, CEO of Isogenica commented, "Our agreement with RCT underlines the
Research Corporation Technologies and BioGrammatics ...www.inknowvation.com › sbir › story › research-corpo...
www.inknowvation.com
... future licensees of Pichia GlycoSwitch to expand the use of this valuable tool for protein production," states Kurt Gehlsen, Ph.D., Chief Scientific Officer at RCT.
RCT Taps Isogenica for Screening Engineered Antibody CH2 Domains
www.genengnews.com
Firm is offering platform of long half-life Abdurins for drug discovery.
sorted by relevance / date